Atom Grants
Discover
  • Dashboard
  • Search
  • Deep Research
  • Favorites
  • Projects

    Studies Addressing Rare Neurodegenerative Diseases including ALS

    Forecasted

    Funds research to develop medical products for treating or curing ALS and other rare neurodegenerative diseases in adults and children.

    Browse similar grants
    Neuroscience Research Grants 2026
    OverviewSimilar Grants
    OverviewSimilar Grants

    Clinical Trials Addressing Unmet Needs of Rare Neurodegenerative Diseases (R01) Clinical Trials Required

    Funds clinical trials for new treatments or labeling changes for rare neurodegenerative diseases in adults and children, aiming to increase FDA-approved therapies.

    HHS-FDA$900,000Forecasted

    Efficient and Innovative Natural History Studies Addressing Unmet Needs in Rare Diseases (R01 Clinical Trials Optional)

    This grant funds innovative natural history studies to improve understanding and support medical product development for rare diseases with unmet needs.

    HHS-FDA$400,000Forecasted

    Reissue of RFA-FD-22-001 - Efficient and Innovative Natural History Studies Addressing Unmet Needs in Rare Diseases (R01 Clinical Trials Optional)

    This grant funds innovative natural history studies to advance medical product development and address unmet needs in rare diseases by generating high-quality, interpretable data.

    HHS-FDADue Jan 7, 2028$2,400,000

    Drug Development RFP

    Drug Development RFP supports researchers and clinicians developing drugs and devices through IND-enabling studies and early clinical trials to advance treatments for Alzheimer’s disease and related dementias.

    Alzheimers Drug DiscoveryDue Dec 7, 2026· 21d$5,000,000

    Identify and Evaluate Potential Risk Factors for Amyotrophic Lateral Sclerosis (ALS)

    CDC/ATSDR seeks research proposals to study and evaluate risk factors for ALS, including environmental, genetic, and population-specific factors, with funding for various research approaches and populations.

    HHS-CDC-HHSCDCERAForecasted Feb 1, 2027$500,000Forecasted